Managing (Multiple) Complex Molecules in CDMO Projects

Life Sciences, Pharma Manufacturing & Supply Chain, Cell and Gene Therapy,
  • Wednesday, January 31, 2024

Join us for an informative webinar exploring the success factors for contract development and manufacturing organization (CDMO) projects with multiple complex molecules.

Gone are the days when biologics development revolved exclusively around simple, monoclonal molecules. Today, customers are embarking on challenging journeys and starting cell line development with multiple complex molecules.

This webinar aims to demystify the process of completing such projects and highlight the essential elements required to bring high-quality molecules seamlessly into the clinic.

Three experts from ProBioGen, drawing from their daily experience, will share their insights and experiences. In an interactive conversation, they reveal the 5 key credentials for successful projects with (multiple) complex molecules.

Instead of a slideshow, you can expect answers to questions such as

  • What else is needed besides scientific expertise?
  • What is the role of technologies such as transposase or platform processes?
  • How important is strong project management and pronounced customer proximity?

Register for this webinar to learn about the key success factors for CDMO projects with multiple complex molecules.


Annika Lubitz, ProBioGen

Annika Lubitz, Director Bioassays (CATS)

Annika Lubitz is Director of the Bioassay Department at ProBioGen, where she is accounting the development, optimization and qualification of various bioactivity assays for potency characterization of biopharmaceuticals such as engineered monoclonal antibodies or fusion proteins.

After graduating as a biotechnology engineer Annika Lubitz joined ProBioGen in 2005. She worked as a research scientist in the Cell and Tissue Services department. There she got involved in numerous projects dealing with immune cell expansion, drug exposure and analytics before she engaged the generation and investigation of in-vitro immune responses using human 3D models. Since 2016, she has been leading the Bioassay department.

Message Presenter
Dr. Thomas Rose, ProBioGen

Dr. Thomas Rose, Head of Expression Systems, ProBioGen

Thomas Rose, PhD, is Head of Expression Systems at ProBioGen. He received his MSc in Biotechnology from the University of Applied Science in Berlin, and his PhD in Biochemistry from the Free University of Berlin and joined ProBioGen in 2001. His work focuses on cell line development and expression technologies for protein drugs. He was instrumental in establishing the Freedom™ CHO-S™ Kit, as well as ProBioGen’s CHORight® platform, Pathway Modulator and DirectedLuck® technologies. He also has extensive experience in cell line development for a variety of complex proteins.

Message Presenter
Dr. Ellen Hilgenberg, ProBioGen

Dr. Ellen Hilgenberg, Senior Business Development Manager, ProBioGen

Dr. Ellen Hilgenberg is the Senior Business Development Manager at ProBioGen. She studied biology and received her PhD in Immunology from the German Rheumatism Research Center in Berlin, Germany. Afterward, she completed her Postdoc at the Max Delbrueck Center in Berlin before she joined ProBioGen.

Message Presenter

Who Should Attend?

This webinar will benefit professionals from companies with multiple and complex molecules in preclinical development, with relevant job titles including:

  • Senior/Director, New Product Strategy & Development
  • Project Leaders/Project Management/CMC-Managers
  • Senior/Director, Product Development
  • Senior/Director, R&D
  • Consultants

What You Will Learn

Attendees will gain insights into:

  • The secret of successful contract development and manufacturing organization (CDMO) projects with multiple complex molecules
  • What does it take to ensure the highest possible quality
  • How to meet challenging timelines
  • What can be learned from multiple other projects

Xtalks Partner


ProBioGen is a leading CDMO and a specialist in developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines.

Combining both state-of-the-art development services, based on ProBioGen’s CHO.RiGHT® expression and manufacturing platform, together with intelligent product-specific technologies yield biologics with optimized properties. Rapid and integrated cell line and process development, comprehensive analytical development and following reliable GMP manufacturing are performed by a highly skilled and experienced team based in Berlin.

For more information about ProBioGen, visit LinkedIn.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account